Adverum Biotechnologies, Inc. Annual Net Cash Provided by (Used in) Investing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Adverum Biotechnologies, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2017 to 2023.
  • Adverum Biotechnologies, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was -$22M, a 202% decline year-over-year.
  • Adverum Biotechnologies, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $96.9M, a 31.6% decline from 2022.
  • Adverum Biotechnologies, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $142M, a 80.1% increase from 2021.
  • Adverum Biotechnologies, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was $78.7M.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.